Volumes low, financiers dumping stock to recoup loans. Next news will probably be publication of Invion smoking cessation trial data in the prestigious American Thoracic Society journal. Directors aren't going to let this play out in an open forum. They know the importance of a deal, and confidentiality is paramount. To my knowledge all individual major shareholders are sensibly holding pending a deal. The science hasn't turned sour, the IP is strong (despite the drug being generic), and the markets are huge. I have been waiting 10 years Twigman, no need to be despondent now, you were just a little premature when you made your call that the stock had bottomed at 1.4 cents a couple of months back. I am prepared to say that .4 cents is the floor. Good luck to all, particularly all long term holders who have been savaged over the years.
IVX Price at posting:
0.5¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)